There was significant anti-tumor activity against pancreatic cancer cell lines and xenograft tumor models expressing both CEA and MSLN, and there was a lack of T-cell activation in the presence of just one antigen. The gene discussed is MSLN; the disease is familial pancreatic carcinoma.